High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy
Jung Eun Lee, Ji Hee Lim, Yong Kil Hong, Seung Ho Yang
Cancer Res Treat. 2018;50(4):1331-1342.   Published online 2018 Jan 10     DOI: https://doi.org/10.4143/crt.2017.466
Citations to this article as recorded by Crossref logo
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
Rashmi R. Shah, Peter D. Stonier
Journal of Clinical Pharmacy and Therapeutics.2019; 44(1): 6.     CrossRef
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
Federica Barbieri, Ivan Verduci, Valentina Carlini, Gianluigi Zona, Aldo Pagano, Michele Mazzanti, Tullio Florio
Frontiers in Oncology.2019;[Epub]     CrossRef
DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy
Yosef Masoudi-Sobhanzadeh, Yadollah Omidi, Massoud Amanlou, Ali Masoudi-Nejad
Computers in Biology and Medicine.2019; 109: 254.     CrossRef
Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway
Chung-Ching Chio, Yu-Ting Tai, Mahendravarman Mohanraj, Shing-Hwa Liu, Shun-Tai Yang, Ruei-Ming Chen
Phytomedicine.2018; 49: 41.     CrossRef
Pleiotropic Effects of Metformin on Cancer
Hans-Juergen Schulten
International Journal of Molecular Sciences.2018; 19(10): 2850.     CrossRef